[Sight Diagnostics in Nasdaq] U.S. FDA clears Israeli startup Sight Diagnostics’ finger prick blood test
Israeli startup Sight Diagnostics said on Wednesday the U.S. Food and Drug Administration had cleared its device that can process results for the most commonly needed blood test in about ten minutes. Read more...
Read More